These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9261042)

  • 1. Scleroderma, D-penicillamine treatment, and progressive renal failure associated with positive antimyeloperoxidase antineutrophil cytoplasmic antibodies.
    Hillis GS; Khan IH; Simpson JG; Rees AJ
    Am J Kidney Dis; 1997 Aug; 30(2):279-81. PubMed ID: 9261042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature.
    Karpinski J; Jothy S; Radoux V; Levy M; Baran D
    Am J Nephrol; 1997; 17(6):528-32. PubMed ID: 9426850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MPO-ANCA-Positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease?
    Anders HJ; Wiebecke B; Haedecke C; Sanden S; Combe C; Schlöndorff D
    Am J Kidney Dis; 1999 Apr; 33(4):e3. PubMed ID: 10196034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Extracapillary glomerulonephritis with anti-myeloperoxidase antibodies in 2 patients with systemic scleroderma treated with penicillamine D].
    Kyndt X; Ducq P; Bridoux F; Reumaux D; Makdassi R; Gheerbrant JD; Vanhille P
    Presse Med; 1999 Jan; 28(2):67-70. PubMed ID: 9989295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineutrophil cytoplasmic autoantibodies (ANCA) and systemic sclerosis.
    Carvajal I; Bernis C; Sanz P; Garcia A; Garcia-Vadillo A; Traver JA
    Nephrol Dial Transplant; 1997 Mar; 12(3):576-7. PubMed ID: 9075145
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapidly progressive glomerulonephritis with D-penicillamine.
    Nanke Y; Akama H; Terai C; Kamatani N
    Am J Med Sci; 2000 Dec; 320(6):398-402. PubMed ID: 11149553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure.
    Katrib A; Sturgess A; Bertouch JV
    Rheumatol Int; 1999; 19(1-2):61-3. PubMed ID: 10651085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case of scleroderma with rapid progressive glomerulonephritis associated with both MPO-ANCA and anti-GBM antibodies].
    Namba T; Hatanaka M; Takahashi A; Takeji M; Takahara K; Uzu T; Yamauchi A
    Nihon Jinzo Gakkai Shi; 2008; 50(1):64-8. PubMed ID: 18318246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease.
    Bienaimé F; Clerbaux G; Plaisier E; Mougenot B; Ronco P; Rougier JP
    Am J Kidney Dis; 2007 Nov; 50(5):821-5. PubMed ID: 17954295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis in scleroderma--a different kind of renal crisis.
    Kamen DL; Wigley FM; Brown AN
    J Rheumatol; 2006 Sep; 33(9):1886-8. PubMed ID: 16832842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANCA-related crescentic glomerulonephritis in a patient with scleroderma without marked dermatological change and malignant hypertension.
    Tomioka M; Hinoshita F; Miyauchi N; Akiyama Y; Saima S; Hiroe M
    Intern Med; 2004 Jun; 43(6):496-502. PubMed ID: 15283187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) related glomerulonephritis associated with systemic sclerosis treated by steroid pulse therapy: a case report].
    Mizutani A; Tanaka I; Katayama M; Oshima H; Komatsu Y; Asano S; Kato K; Matsumura H; Ishii K; Miyama H; Nagai T; Kato K; Fukaya S; Yoshida S; Hasegawa M; Kawashima S; Torikai K
    Ryumachi; 2000 Oct; 40(5):828-32. PubMed ID: 11215162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-penicillamine induced crescentic glomerulonephritis: report and review of the literature.
    Devogelaer JP; Pirson Y; Vandenbroucke JM; Cosyns JP; Brichard S; Nagant de Deuxchaisnes C
    J Rheumatol; 1987 Oct; 14(5):1036-41. PubMed ID: 3430507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of progressive systemic sclerosis with crescentic glomerulonephritis associated with myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) and anti-glomerular basement membrane antibody (anti-GBM Ab)].
    Kobayashi M; Saito M; Minoshima S; Arimura Y; Nagasawa T
    Nihon Jinzo Gakkai Shi; 1995 Mar; 37(3):207-11. PubMed ID: 7731110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibodies -- related scleroderma renal crisis treated with double-filtration plasmapheresis.
    Omote A; Muramatsu M; Sugimoto Y; Hosono S; Murakami R; Tanaka H; Watanabe Y; Sano H; Kato K
    Intern Med; 1997 Jul; 36(7):508-13. PubMed ID: 9240503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Progressive systemic sclerosis associated with anti-myeloperoxidase ANCA vasculitis with renal and cutaneous involvement].
    Martínez Ara J; Picazo ML; Torre A; Pascual D; Díaz Rodríguez C; Riñón C
    Nefrologia; 2000; 20(4):383-6. PubMed ID: 11039266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manifest interstitial and vascular pathology in anti-neutrophil cytoplasmic antibody-associated renal disease.
    Haridasan S; Ganesh RN; Parameswaran S; Priyamvada PS
    Saudi J Kidney Dis Transpl; 2019; 30(3):726-734. PubMed ID: 31249242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience on antineutrophil cytoplasm antibodies and antimyeloperoxidase antibodies in rapidly progressive glomerulonephritis.
    Rollino C; Roccatello D; Coppo R; Menegatti E; Basolo B; Giraudo G; Martina G; Piccoli G
    Contrib Nephrol; 1991; 94():101-6. PubMed ID: 1687269
    [No Abstract]   [Full Text] [Related]  

  • 19. Crescentic glomerulonephritis accompanied by myeloperoxidase-antineutrophil cytoplasmic antibodies in a patient having myelodysplastic syndrome with trisomy 7.
    Komatsuda A; Miura I; Ohtani H; Hamai K; Wakui H; Imai H; Kobayashi Y; Miura AB; Chubachi A
    Am J Kidney Dis; 1998 Feb; 31(2):336-40. PubMed ID: 9469507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma with type III glomerulonephritis and MPO-ANCA antibodies in the serum.
    Herrera-Esparza R; Aguilar JL; Saucedo A; González I; López-Robles E; Avalos-Díaz E
    J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):617-20. PubMed ID: 16164722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.